In vivo studies on the effects of α1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits

被引:0
作者
Martin C. Michel
Hiroko Okutsu
Yukiko Noguchi
Masanori Suzuki
Akiyoshi Ohtake
Hironori Yuyama
Hiroko Yanai-Inamura
Masashi Ukai
Mai Watanabe
Akiyoshi Someya
Masao Sasamata
机构
[1] University of Amsterdam,Department of Pharmacology and Pharmacotherapy, Academic Medical Centre
[2] Astellas Pharma Inc.,Applied Pharmacology II, Pharmacology Research Labs, Drug Discovery Research
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 2006年 / 372卷
关键词
Alfuzosin; Doxazosin; Naftopidil; Prazosin; Tamsulosin; Terazosin; Miosis; Iris; Pupil;
D O I
暂无
中图分类号
学科分类号
摘要
α1-Adrenoceptors mediate contraction of iris dilator smooth muscle and hence pupil dilatation. We compared the ability of i.v. bolus injections of alfuzosin, doxazosin, naftopidil, prazosin, tamsulosin and terazosin to antagonise phenylephrine-induced mydriasis relative to their potency for inhibiting phenylephrine-induced elevations of intraurethral pressure (IUP) in rabbits. Moreover, we compared the ability of these drugs to induce miosis in conscious rabbits in the absence of phenylephrine. All antagonists inhibited the effects of phenylephrine on pupil size and IUP, and the ratio of the respective ED50 values was close to unity in all cases. The doses required to induce statistically significant miosis in the absence of phenylephrine were 30- to 100-fold higher than those inhibiting phenylephrine-induced mydriasis for all antagonists, except for naftopidil. Moreover, the miotic effects of all α1-adrenoceptor antagonists were fully reversible within 8 h. We conclude that alfuzosin, doxazosin, naftopidil, prazosin, tamsulosin and terazosin inhibit phenylephrine-induced mydriasis in the same dose range as they inhibit elevations in IUP. Higher doses of all antagonists are required to induce miosis in the absence of an exogenous agonist, and such miosis is always reversible within hours.
引用
收藏
相关论文
共 141 条
[1]  
Chang DF(2005)Intraoperative floppy iris syndrome associated with tamsulosin J Cataract Refract Surg 31 664-673
[2]  
Campbell JR(2001)Flesinoxan, a 5-HT Curr Eye Res 23 144-153
[3]  
Chidlow G(1997) receptor agonist/α Invest Ophthalmol Vis Sci 38 855-865
[4]  
Cupido A(2003)-adrenoceptor antagonist, lower intraocular pressure in NZW rabbits J Neurophysiol 89 3179-3189
[5]  
Melena J(1995)Stimulation of P2U purinergic or α Eur J Pharmacol 288 201-207
[6]  
Osborne NN(1998) adrenergic receptors mobilizes Ca2+ in lens cells Cell Tissue Res 293 435-444
[7]  
Churchill GC(1970)Characteristics of the pupillary light reflex in the alert rhesus monkey Am J Ophthalmol 70 729-733
[8]  
Louis CF(1988)Use of recombinant α J Auton Pharmacol 8 229-239
[9]  
Clarke RJ(1993)-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy J Auton Nerv Syst 45 107-123
[10]  
Zhang H(2005)Immunohistochemical localisation of α Invest Ophthalmol Vis Sci 46 2781-2789